Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, USA.
Subcell Biochem. 2024;104:409-423. doi: 10.1007/978-3-031-58843-3_15.
The hemostatic response to vascular injury entails a sequence of proteolytic events where several inactive zymogens of the trypsin family are converted to active proteases. The cascade starts with exposure of tissue factor from the damaged endothelium and culminates with conversion of prothrombin to thrombin in a reaction catalyzed by the prothrombinase complex composed of the enzyme factor Xa, cofactor Va, Ca, and phospholipids. This cofactor-dependent activation is paradigmatic of analogous reactions of the blood coagulation and complement cascades, which makes elucidation of its molecular mechanism of broad significance to the large class of trypsin-like zymogens to which prothrombin belongs. Because of its relevance as the most important reaction in the physiological response to vascular injury, as well as the main trigger of pathological thrombotic complications, the mechanism of prothrombin activation has been studied extensively. However, a molecular interpretation of this mechanism has become available only recently from important developments in structural biology. Here we review current knowledge on the prothrombin-prothrombinase interaction and outline future directions for the study of this key reaction of the coagulation cascade.
血管损伤的止血反应涉及一系列蛋白水解事件,其中几种无活性的胰蛋白酶家族酶原被转化为活性蛋白酶。级联反应始于损伤内皮细胞中组织因子的暴露,并以凝血酶原在由酶因子 Xa、辅因子 Va、Ca 和磷脂组成的凝血酶原酶复合物催化的反应中转化为凝血酶而告终。这种辅因子依赖性激活是类似的血液凝固和补体级联反应的典型反应,这使得阐明其分子机制对属于凝血酶原的一大类胰蛋白酶样酶原具有广泛的意义。由于其作为血管损伤生理反应中最重要的反应以及病理血栓并发症的主要触发因素,凝血酶原的激活机制已被广泛研究。然而,只有最近在结构生物学的重要发展中,才对该机制有了分子解释。在这里,我们回顾了凝血酶原-凝血酶原酶相互作用的最新知识,并概述了该凝血级联反应关键反应的研究方向。